|
|
You are subscribed to receive research study announcements from the National Institutes of Health (NIH) Clinical Center. To learn more about this NIH study #001554-C, or other studies, please call us at 833-JOIN-NIH.
Seeking Adults and Children with MDS or MDS/MPN
Dr. El Jurdi and her team at the National Institutes of Health (NIH) are seeking adults and children aged 12 and older with myelodysplastic syndrome (MDS) or myelodysplastic/myeloproliferative neoplasm (MDS/MPN) for a clinical research study. This clinical research study is evaluating the safety and effectiveness of an investigational drug, pacritinib. Parental consent is required for minors.
What to Expect
- Screening period: one to four weeks
- Medical history review and physical exam
- Blood tests, including infection screening and pregnancy testing echocardiogram
- Heart tests, including an ECG and echocardiogram
- Bone marrow biopsy, if needed to confirm your diagnosis
If you qualify:
- Take the study drug twice a day by mouth
- Have standard blood tests at regular intervals
- Attend study visits at regular intervals while taking the study drug
- Participate in the study for up to 8 years
Study conducted at the NIH Clinical Center in Bethesda, MD
|
|
|
Interested in Participating in Research?
| | |
